Study Results Adding LC to the Krebs solution as a pharmacological agent in post-conditioning from 10 minutes before the start of reperfusion to 10 minutes afterward showed heart protective effects, including a reduction in infarct size
Some studies, though not conclusive, predict that tirzepatide may in fact be more potent than GLP-1 RAs at reducing weight
What I have done is stuck to my laboratory, to the science, and then tried to explain that to the companies to say, look here, this is interesting.
In addition, most RCTs designed to test the renoprotective effect of SGLT2i or GLP-1RA in patients with DKD maintained the RAS blocker as the standard of care (Wanner et al., 2016
C., Singel, D., Steinmetz, S., Hepburn, S., & Brown, M
What if I experience nausea